Literature DB >> 28050658

Development of a Searchable Database of Cryoablation Simulations for Use in Treatment Planning.

F Edward Boas1, Govindarajan Srimathveeravalli2, Jeremy C Durack2, Elena A Kaye3, Joseph P Erinjeri2, Etay Ziv2, Majid Maybody2, Hooman Yarmohammadi2, Stephen B Solomon2.   

Abstract

PURPOSE: To create and validate a planning tool for multiple-probe cryoablation, using simulations of ice ball size and shape for various ablation probe configurations, ablation times, and types of tissue ablated.
MATERIALS AND METHODS: Ice ball size and shape was simulated using the Pennes bioheat equation. Five thousand six hundred and seventy different cryoablation procedures were simulated, using 1-6 cryoablation probes and 1-2 cm spacing between probes. The resulting ice ball was measured along three perpendicular axes and recorded in a database. Simulated ice ball sizes were compared to gel experiments (26 measurements) and clinical cryoablation cases (42 measurements). The clinical cryoablation measurements were obtained from a HIPAA-compliant retrospective review of kidney and liver cryoablation procedures between January 2015 and February 2016. Finally, we created a web-based cryoablation planning tool, which uses the cryoablation simulation database to look up the probe spacing and ablation time that produces the desired ice ball shape and dimensions.
RESULTS: Average absolute error between the simulated and experimentally measured ice balls was 1 mm in gel experiments and 4 mm in clinical cryoablation cases. The simulations accurately predicted the degree of synergy in multiple-probe ablations. The cryoablation simulation database covers a wide range of ice ball sizes and shapes up to 9.8 cm.
CONCLUSION: Cryoablation simulations accurately predict the ice ball size in multiple-probe ablations. The cryoablation database can be used to plan ablation procedures: given the desired ice ball size and shape, it will find the number and type of probes, probe configuration and spacing, and ablation time required.

Entities:  

Keywords:  Cryoablation; Planning; Prediction; Simulation

Mesh:

Year:  2017        PMID: 28050658      PMCID: PMC5374014          DOI: 10.1007/s00270-016-1562-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  19 in total

1.  Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.

Authors:  Grant D Schmit; Thomas D Atwell; Matthew R Callstrom; Michael A Farrell; Bradley C Leibovich; David E Patterson; George K Chow; Michael L Blute; J William Charboneau
Journal:  J Endourol       Date:  2010-08       Impact factor: 2.942

2.  Microvascular contributions in tissue heat transfer.

Authors:  M M Chen; K R Holmes
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

3.  Are multiple cryoprobes additive or synergistic in renal cryotherapy?

Authors:  Jennifer L Young; David W McCormick; Surrendra B Kolla; Petros G Sountoulides; Oskar G Kaufmann; Cervando G Ortiz-Vanderdys; Victor B Huynh; Adam G Kaplan; Nick S Jain; Donald L Pick; Lorena A Andrade; Kathryn E Osann; Elspeth M McDougall; Ralph V Clayman
Journal:  Urology       Date:  2011-12-20       Impact factor: 2.649

Review 4.  Cryoablation: mechanism of action and devices.

Authors:  Joseph P Erinjeri; Timothy W I Clark
Journal:  J Vasc Interv Radiol       Date:  2010-08       Impact factor: 3.464

5.  Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial.

Authors:  Matthew R Callstrom; Damian E Dupuy; Stephen B Solomon; Robert A Beres; Peter J Littrup; Kirkland W Davis; Ricardo Paz-Fumagalli; Cheryl Hoffman; Thomas D Atwell; J William Charboneau; Grant D Schmit; Matthew P Goetz; Joseph Rubin; Kathy J Brown; Paul J Novotny; Jeff A Sloan
Journal:  Cancer       Date:  2012-10-12       Impact factor: 6.860

6.  Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year.

Authors:  Thierry de Baere; Lambros Tselikas; David Woodrum; Fereidoun Abtin; Peter Littrup; Frederic Deschamps; Robert Suh; Hussein D Aoun; Matthew Callstrom
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

7.  Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?

Authors:  J Louis Hinshaw; Meghan G Lubner; Timothy J Ziemlewicz; Fred T Lee; Christopher L Brace
Journal:  Radiographics       Date:  2014 Sep-Oct       Impact factor: 5.333

8.  Pneumodissection for skin protection in image-guided cryoablation of superficial musculoskeletal tumours.

Authors:  Majid Maybody; Peter Q Tang; Chaya S Moskowitz; Meier Hsu; Hooman Yarmohammadi; F Edward Boas
Journal:  Eur Radiol       Date:  2016-06-10       Impact factor: 5.315

9.  A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072.

Authors:  Rache M Simmons; Karla V Ballman; Charles Cox; Ned Carp; Jennifer Sabol; Rosa F Hwang; Deanna Attai; Michael Sabel; David Nathanson; Andrew Kenler; Linsey Gold; Cary Kaufman; Linda Han; Aaron Bleznak; J Stanley Smith; Dennis Holmes; Bruno Fornage; Carisa Le-Petross; Syed Hoda; Linda McCall; Kelly K Hunt
Journal:  Ann Surg Oncol       Date:  2016-05-24       Impact factor: 5.344

10.  Modeling Cryotherapy Ice Ball Dimensions and Isotherms in a Novel Gel-based Model to Determine Optimal Cryo-needle Configurations and Settings for Potential Use in Clinical Practice.

Authors:  Taimur T Shah; Uri Arbel; Sonja Foss; Andrew Zachman; Simon Rodney; Hashim U Ahmed; Manit Arya
Journal:  Urology       Date:  2016-02-20       Impact factor: 2.649

View more
  1 in total

1.  Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors.

Authors:  Tim J van Oostenbrugge; Jan Heidkamp; Michael Moche; Phil Weir; Panchatcharam Mariappan; Ronan Flanigan; Mika Pollari; Stephen Payne; Marina Kolesnik; Sjoerd F M Jenniskens; Jurgen J Fütterer
Journal:  Cardiovasc Intervent Radiol       Date:  2020-09-15       Impact factor: 2.740

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.